Intervention

Sertindole

ClinicalTrials.gov intervention label

Clinical trials12
Recruiting0
Common conditions8
Lead sponsors shown7

Clinical trials

12 shown
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic PatientsNCT02307396 · 2015-02-01
COMPLETED
Pharmacovigilance in Gerontopsychiatric PatientsNCT02374567 · 2015-01-01
TERMINATED
Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)NCT00885690 · 2009-04-01
TERMINATED
Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus RisperidoneNCT00480844 · 2008-10-01
UNKNOWN
The Effect of Sertindole and Risperidone on Endophenotypic Markers of SchizophreniaNCT02021201 · 2008-07-01
TERMINATED
Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With SchizophreniaNCT00654706 · 2008-03-01
COMPLETED
The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic PatientsNCT00629252 · 2008-02-01
TERMINATED
Safety Study of an Antipsychotic, Sertindole, to Treat SchizophreniaNCT00763438 · 2007-11-01
COMPLETED
Study on Metabolic Parameters of Sertindole in Patients With SchizophreniaNCT00759460 · 2007-03-01
COMPLETED
Sertindole in Asian Patients With SchizophreniaNCT00864045 · 2007-03-01
COMPLETED
Exploratory Cognition Study of Sertindole in Patients With SchizophreniaNCT00759421 · 2006-10-01
COMPLETED
Safety Study of Sertindole Versus Risperidone Under Normal Conditions of UseNCT00856583 · 2002-07-01
COMPLETED

Trial status mix

COMPLETED7
TERMINATED4
UNKNOWN1

Phase mix

PHASE36
PHASE44
NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.